期刊文献+

高效液相色谱法测定注射用硫酸头孢噻利的含量 被引量:13

Determination of Cefoselis Sulsate for lnjecton by HPLC
下载PDF
导出
摘要 目的:建立高效液相色谱测定注射用硫酸头孢噻利含量的方法。方法:采用反相高效液相色谱法。固定相为十八烷基硅烷键合硅胶(150 mm×6 mm,Shim-Pack CLC-ODS),流动相为乙腈:pH 6.5磷酸盐缓冲液(取0.2 mol/L磷酸二氢钾50 mL与0.2 mol/L氢氧化钠溶液15.20 mL,混合,并加水至200 mL)(12:88),流量为1.0ml/min,检测波长为254nm。结果:硫酸头孢噻利的线性范围为2.084~18.756 lag/mL;相关系数为1.000。注射用硫酸头孢噻利平均含量为99.53%,相对平均偏差为0.39%。结论:该方法简便、准确、专属,可用于注射用硫酸头孢噻利的含量测定。 Objective: To establish RP-HPLC method to determine the content of cefoselis sulfate for injecton. Methods: The RP-C8 Column(150 mm× 6 mm, Shim-Pack CLC-ODS)was used as the stationary phase with a mobile phase of acetonitrile : pH 6.5 phosphate buffer (0.2 mol/L potassium dihydrogen phosphate 50 mL and 0.2 mol/L sodium hydroxide solution 15.20 mL water is added to 200 mL)(12:88).The flow rate was 1.0 ml/min and the detection wavelength was 254 nm. Results:The linear range was 2.084-18.756 μg/mL; correlation coefficients were 1.000. The average content(n = 6) of cefoselis sulfate was 99.53% and RSD was 0.39%. Conclusion: The mothod is sample, accurate and specific. It can be used for the determination of the cefoselis sulfate for injecton.
出处 《抗感染药学》 2007年第4期169-171,共3页 Anti-infection Pharmacy
关键词 高效液相色谱法 注射用硫酸头孢噻利 含量 HPLC cefoselis sulsate for injection content
  • 相关文献

参考文献2

二级参考文献16

  • 1Martinez- Beltran J,Canton R, Linares J, et al. Multicentre comparative study on the antibacterial activity of FK- 037, a new parenteral cephalosporin[J].Eur J Clin Microbiol Infect Dis, 1995, 14(3): 244.
  • 2Giamarellos- Bourboulis EJ, Grecka P, Tsitsika A, et al. In- vitro activity of FK 037(Cefoselis), a novel 4(th) generation cephalosporin, compared to cefepime and cefpirome on nosocomial staphylococci and gram- negative isolates[J]. Diagn Microbiol Infect Dis, 2000, 36(3): 185.
  • 3Inoue K, Inoue E, Mitsuhashi S. In vitro antibacterial activities of FK037: a new parenteral cephalosporin[J]. Chemotherapy, 1995, 41(4): 257.
  • 4Climo MW, Markowitz SM, Williams DS, et al.Compari- son of the in- vitro and in- vivo efficacy of FK037, van- comycin, imipenem and nafcillin against staphylococcal specie[J]. J Antimicrob Chemother, 1997, 40(1): 59.
  • 5Kato N, Kato H, Tanaka Y, et al.In vitro activity of FK037, a new parenteral cephalosporin, against anaerobic bacteria[J]. Antimicrob Agents Chemother, 1993, 37(5): 957.
  • 6Fu KP, Foleno BD, Lafredo SC,et al.In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad- spectrum cephalosporin[J]. Antimicrob Agents Chemother, 1993, 37(2): 301.
  • 7Hanaki H, Hiramatsu K. Combination effect of teicopl- anin and various antibiotics against hetero- VRSA and VRSA[J]. Kansenshogaku Zasshi, 1999, 73(10): 1 048.
  • 8Houston AK, Jones RN.Post- antibiotic effect of FK- 037 and biapenem tested against five bacterial species[J]. J Chemother, 1994, 6(1): 12.
  • 9Sakamoto H, Hatano K, Higashi Y, et al.Animal pharmacokinetics of FK037, a novel parenteral broad- spec- trum cephalosporin[J].J Antibiot (Tokyo), 1993, 46(1): 120.
  • 10Wise R, Andrews JM, O'Neill P, et al.Pharmacokineti- cs and distribution in tissue of FK- 037, a new parent- eral cephalosporin[J]. Antimicrob Agents Chemother, 1994, 38(10): 2 369.

共引文献49

同被引文献43

引证文献13

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部